LLY : Analysis & Opinions

  1. Eli Lilly President/CEO to Retire at Year's End

    July 28, 2016
    This will be the final year of Eli Lilly (NYSE: LLY) President and CEO John Lechleiter's tenure. The company has announced ...
  2. (ADHD) Who are Alcobra's Main Competitors?

    May 8, 2016
    Learn about Alcobra, a young player in treating attention deficit hyperactiviy disorder (ADHD) that may give its competitors ...
  3. Eli Lilly Stock Surge Ahead of Earnings (LLY)

    April 25, 2016
    As analysts increased the company's profit forecasts, LLY stock responded favorably. But there's not much room left for multiple ...
  4. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  5. 3 Best Dividend-Paying U.S. Health Care Mutual Funds (VGHCX, ...

    April 2, 2016
    Find out which mutual funds are paying the highest dividend yields in the health care sector, which has underperformed all ...
  6. In Pain? Sanofi Has a Cure for That (SNY)

    January 30, 2016
    Sanofi, a French pharmaceutical firm, is the name behind some of the drugs you use every day. Here's how it operates.
  7. 5 'Boring' Dividend Stocks for a Market Sell-off

    January 26, 2016
    Finding the right dividend stocks for bear markets isn't about seeking the highest yield. Instead, consider these five fiscally-solid ...
  8. How Novartis Probably Has a Cure for What Ails You

    January 21, 2016
    A look at the unparalleled growth of the world's biggest pharmaceutical company: Novartis AG.
  9. Is Eli Lilly Now a Solid Income Investor Play?

    December 10, 2015
    Pharmaceutical giant Eli Lilly (NYSE: LLY) has declared a fresh dividend raise, albeit an incremental one. The company has ...
  10. Drugmaker Extraordinaire: How Eli Lilly Grows

    August 7, 2015
    Drugs mean big profits in America. Here's how the country's oldest pharmaceutical firm keeps its toehold in the market.
  11. Biogen Earnings Preview: 3 Key Factors to Monitor (BIIB, LLY)

    April 14, 2015
    For the better part of a decade, Biogen (NASDAQ: BIIB) could simply do no wrong by its shareholders. Whereas the S&P ...
  12. Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  13. Novo Nordisk Getting Its Trial By Fire

    August 8, 2013
    Novo Nordisk is facing more challenges than it has in a while, but the growth remains strong.
  14. Investing For The Global Diabetes Epidemic

    May 31, 2013
    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with ...
  15. 10 Drug Stocks for Safety and Yields

    June 26, 2011
    Big pharma is an attractive destination for traders and investors looking for safety, yields, and solid value in the current ...
  16. Novo Nordisk Still One Of The Best Around

    May 3, 2011
    Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.
  17. Top 3 Sectors For Value Investors

    February 8, 2011
    As the U.S. economy has recovered, so have the equity markets. Learn the best-value sectors that investors should focus on.
Trading Center